Probiotic supplements protected female mice from the loss of bone density that occurs after having their ovaries removed, researchers have shown in Journal of Clinical Investigation.
In mice, ovary removal induces the hormonal changes that occur with menopause in women. The findings suggest that probiotic bacteria may have potential as an inexpensive treatment for post-menopausal osteoporosis. However, clinical evidence that probiotics can have a lasting effect on the mix of bacteria in the body is limited.
The immune system was known to be involved in post-menopausal osteoporosis, but the mechanism was previously unclear. Researchers found that in mice, the loss of estrogen increases gut permeability, which allows bacterial products to activate immune cells in the intestine. In turn, immune cells release signals that break down bone. Probiotics both tighten up the permeability of the gut and dampen inflammatory signals that drive the immune cells, the team found.
"Our findings highlight the role that intestinal microbes play in modulating gut permeability and inflammation in the context of sex steroid depletion," says senior author. "We think there are direct implications for the treatment of osteoporosis that should be tested clinically."
Researchers treated female mice twice a week with Lactobacillus rhamnosus GG (LGG), a type of bacteria found in some yogurts, or with a commercially available mix of eight strains of bacteria known as VSL#3.
A month after ovary removal, mice that were not treated with probiotic bacteria had lost half of their bone density. But the bone density in probiotic-treated mice stayed the same, the researchers observed.
The type of bacteria was important; treating mice with a laboratory strain of E. coli bacteria lacking probiotic properties did not help, and a mutant LGG bacteria with a defect in sticking to intestinal cells provided a weakened protective effect. In mice that did not have their ovaries removed, probiotic treatment actually led to an increase in bone density.
The scientists also tested the role of gut bacteria in bone loss by studying mice that were raised under germ-free conditions. In this situation, surgical ovary removal is not feasible so the research team used the drug leuprolide, which reduces hormone production by the ovaries. Germ-free mice treated with leuprolide do not have a reduction in bone density.
"What this means is that the presence of some intestinal bacteria is required for sex steroid depletion-induced bone loss", says co-author. "We observed increased gut permeability following sex steroid depletion. As a result, it is likely that more particles from intestinal bacteria enter the gut tissue and activate immune cells that are known to cause bone loss".
Current investigations are focused on assessing the diversity of the gut microbiome following sex steroid depletion. "One possibility is that sex steroid deficiency leads to decreased microbiota diversity that exacerbate bone loss, and that probiotics preserve greater diversity," author says.
https://www.jci.org/articles/view/86062
Probiotics stop menopause-like bone loss in mice
- 2,082 views
- Added
Edited
Latest News
Protein that helps COVID-19…
By newseditor
Posted 26 Jul
Spinal Muscular Atrophy (SM…
By newseditor
Posted 26 Jul
Link between bowel movement…
By newseditor
Posted 26 Jul
Inhibition of IL-11 signall…
By newseditor
Posted 25 Jul
Brain changes linked to obe…
By newseditor
Posted 25 Jul
Other Top Stories
Deep-sleep brain waves predict blood sugar control
Read more
Extracellular cytochrome nanowires appear to be ubiquitous in microbes
Read more
Distinct connectivity patterns for depression associated with traum…
Read more
Antisense therapy restores fragile X protein production in human cells
Read more
Biomarker for allergic reaction in kidneys identified!
Read more
Protocols
A systems biology approach…
By newseditor
Posted 24 Jul
quantms: a cloud-based pipe…
By newseditor
Posted 22 Jul
Emerging tools and best pra…
By newseditor
Posted 19 Jul
Directly selecting cell-typ…
By newseditor
Posted 17 Jul
PUFFFIN: an ultra-bright, c…
By newseditor
Posted 16 Jul
Publications
Hepatocyte-intrinsic SMN de…
By newseditor
Posted 26 Jul
Aberrant bowel movement fre…
By newseditor
Posted 26 Jul
A pseudoautosomal glycosyla…
By newseditor
Posted 26 Jul
Microglia protect against a…
By newseditor
Posted 26 Jul
Rigor and reproducibility i…
By newseditor
Posted 26 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar